share_log

Recursion Pharmaceuticals | 144: Notice of proposed sale of securities pursuant to Rule 144

SEC announcement ·  Jun 6 00:31
Summary by Futu AI
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 50,000 Class A shares of the company, with an aggregate market value of $421,000, on 06/05/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned transaction follows a series of sales over the past three months, where Gibson sold a total of 356,319 shares, amounting to gross proceeds of approximately $3.35 million.
Christopher Gibson, an officer and director at Recursion Pharmaceuticals, Inc., is set to sell 50,000 Class A shares of the company, with an aggregate market value of $421,000, on 06/05/2024. These shares were originally acquired on 09/01/2016 as founders shares, a form of compensation from the issuer. This planned transaction follows a series of sales over the past three months, where Gibson sold a total of 356,319 shares, amounting to gross proceeds of approximately $3.35 million.
Helpful
Not Helpful

This announcement is a separate document:

Doc 1

The information provided by Futu AI is automatically generated by third-party artificial intelligence (AI) software based on news content. It is only available to users located outside of China mainland.


The above content is for informational or educational purposes only and does not constitute any investment advice related to Futu. Although we strive to ensure the truthfulness, accuracy, and originality of all such content, we cannot guarantee it.